share_log

Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 15 06:38
Summary by Futu AI
Merck & Co. Inc. officer Robert M. Davis is set to sell 85,021 shares of the company's common stock on February 14, 2024, according to a recent filing. The shares, valued at an aggregate market value of $10,661,573.89, were acquired on the same date through the exercise of options under a registered plan. The transaction involves the payment of cash to the issuer for the securities. This sale follows a previous transaction in the past three months where Davis sold 150,000 shares for a total gross proceed of $18,872,130.
Merck & Co. Inc. officer Robert M. Davis is set to sell 85,021 shares of the company's common stock on February 14, 2024, according to a recent filing. The shares, valued at an aggregate market value of $10,661,573.89, were acquired on the same date through the exercise of options under a registered plan. The transaction involves the payment of cash to the issuer for the securities. This sale follows a previous transaction in the past three months where Davis sold 150,000 shares for a total gross proceed of $18,872,130.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.